"Will they cover this?"
You know what you want to prescribe. Manoa confirms whether it'll be approved, what's required, and surfaces alternatives you should know about before you commit.
Coverage intelligence for clinicians
The coverage answer your EHR can't give you.
Describe a patient in plain language. Manoa returns every realistic treatment option — covered and not — with the coverage path, the cash-pay path, and the cost on each. No PHI required.
iOS · TestFlight access for early users · No spam, ever.
The problem
Clinicians are making coverage decisions with no real visibility into coverage.
Every prescription carries a hidden second question: will this patient's plan actually cover it? Today, the answer lives across a dozen places — and none of them were built to answer it. So clinicians make their best guess, write the prescription, and hope the patient doesn't get a surprise at the pharmacy counter.
What clinicians use today
EHR formulary check
Vague yes or no, one drug at a time, no reasoning.
Payer policy PDFs
Hundreds of pages per plan, constantly changing.
ChatGPT / Google
Smart about medicine, blind to this patient's plan.
From our design partners
Clinicians on the gap, in their words.
“They won't cover that. Well what will they cover? This is where you waste the most amount of time. I don't have x-ray vision to know the rest of what can be covered instead. I'd use that.”
“It's like navigating an information jungle to answer what is covered for this patient, this product, this insurance, this condition, and this time.”
The product
One question. Every realistic option. Ranked.
Manoa is a chat-based mobile app for clinicians. Describe a patient the way you'd describe them to a colleague. Manoa returns a side-by-side comparison of treatment options for this specific patient and this specific plan, with coverage likelihood, step therapy requirements, estimated cost, speed to approval, and a cash-pay alternative for every option.
Tier 1 · Strong
Dupixent
dupilumab · 300 mg SC q2w
- Step therapy
- 3 of 3 met
- Est. cost
- $0–35 / mo
- Approval
- ~2 weeks
Tier 2 · Worth considering
Nucala
mepolizumab · 100 mg SC q4w
- Step therapy
- 2 of 3 met
- Est. cost
- $50–120 / mo
- Approval
- 3–4 weeks
Tier 3 · Long shot
Ohtuvayre
ensifentrine · 3 mg INH BID
- Step therapy
- Not satisfied
- Est. cost
- Appeal-dependent
- Approval
- 6+ weeks
Illustrative example — 62-year-old patient with severe eosinophilic COPD on Aetna Commercial PPO (CA). Real coverage depends on the live plan policy.
How it works
Three steps. Three minutes. No setup.
- 1
Describe
Tell Manoa about the patient.
Type or talk. Condition, plan, anything else you know. Partial inputs are fine — Manoa asks follow-up questions to fill in what matters.
- 2
Compare
See every realistic option.
Manoa returns a ranked comparison across coverage, cost, step therapy, and speed. Drill into any option to see why it's covered, what's required, and the cash-pay path.
- 3
Decide
Walk into the room with real options.
Pick the right path with full visibility into what's actually accessible for this patient. No more best guesses. No more pajama-time research.
Built for the way you actually work
Whether you know what to prescribe or you don't.
"What should I prescribe?"
Outside your usual scope, or the case is complicated. Manoa shows you the full landscape of clinically appropriate options ranked by what's accessible for this patient.
"Insurance is a dead end."
When the plan won't budge, Manoa shifts to cash pricing, patient assistance programs, biosimilars, and generics. The goal is the patient getting treated, not the prescription getting approved.
Get early access on iOS.
Manoa is rolling out via TestFlight to clinicians at small and mid-sized private practices. Add your email and we'll send you an invite as soon as we have a seat for you.
We don't sell or share your information. Manoa is designed for queries without PHI — no patient names, MRNs, or other identifiers. Unsubscribe at any time.